Lantern Pharma第三季度每股收益$（0.39）击败$（0.54）估计

Lantern Pharma (NASDAQ: LTRN) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.54) by 27.78 percent. This is a 7.14 percent increase over losses of $(0.42) per share from the same period last year.